Intellia Therapeutics
NTLA
$20.76
Share price
3.70%
Change (1 day)
-42.79%
Change (1 year)
Intellia Therapeutics (NTLA) - Cash on Hand
Cash on Hand as of December 2023 : $0.91 B
According to Intellia Therapeutics's latest financial reports the company has $0.91 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Intellia Therapeutics - Cash on Hand chart (from 2015 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.91 B | -23.51% |
| 2022-12-31 | $1.19 B | 59.29% |
| 2021-12-31 | $0.74 B | 25.33% |
| 2020-12-31 | $0.59 B | 113.56% |
| 2019-12-31 | $0.27 B | -10.93% |
| 2018-12-31 | $0.31 B | -7.81% |
| 2017-12-31 | $0.34 B | 24.76% |
| 2016-12-31 | $0.27 B | 260.17% |
| 2015-12-31 | $75.81 M | 670.1% |
| 2014-12-31 | $9.84 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -77.18% | 🇺🇸 USA |